Prevalence and outcomes of multimorbidity in South Asia:a systematic review by Pati, Sanghamitra et al.
                          Pati, S., Swain, S., Hussain, M. A., van den Akker, M., Metsemakers, J.,
Knottnerus, J. A., & Salisbury, C. (2015). Prevalence and outcomes of
multimorbidity in South Asia: a systematic review. BMJ Open, 5(10),
[e007235]. DOI: 10.1136/bmjopen-2014-007235
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1136/bmjopen-2014-007235
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMJ at
http://bmjopen.bmj.com/content/5/10/e007235. Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Prevalence and outcomes of
multimorbidity in South Asia:
a systematic review
Sanghamitra Pati,1 Subhashisa Swain,1 Mohammad Akhtar Hussain,2
Marjan van den Akker,3,4 Job Metsemakers,3 J André Knottnerus,3 Chris Salisbury5
To cite: Pati S, Swain S,
Hussain MA, et al. Prevalence
and outcomes of
multimorbidity in South Asia:
a systematic review. BMJ
Open 2015;5:e007235.
doi:10.1136/bmjopen-2014-
007235
▸ Prepublication history and
additional material is
available. To view please visit
the journal (http://dx.doi.org/
10.1136/bmjopen-2014-
007235).
Received 21 November 2014
Revised 8 July 2015
Accepted 19 July 2015
For numbered affiliations see
end of article.
Correspondence to
Dr Sanghamitra Pati;
sanghamitra.pati@iiphb.org
ABSTRACT
Objective: To systematically review the studies of
prevalence, patterns and consequences of
multimorbidity reported from South Asia.
Design: Systematic review.
Setting: South Asia.
Data sources: Articles were retrieved from two
electronic databases (PubMed and Embase) and from
the relevant references lists. Methodical data extraction
according to Preferred Reporting Items for Systematic
reviews and Meta-Analyses (PRISMA) guidelines was
followed. English-language studies published between
2000 and March 2015 were included.
Eligibility criteria: Studies addressing prevalence,
consequences and patterns of multimorbidity in South
Asia. Articles documenting presence of two or more
chronic conditions were included in the review. The quality
and risk of bias were assessed using STROBE criteria.
Data selection: Two reviewers independently assessed
studies for eligibility, extracted data and assessed study
quality. Due to heterogeneity in methodologies among
reported studies, only narrative synthesis of the results
was carried out.
Results: Of 11 132, 61 abstracts were selected and 13
were included for final data synthesis. The number of
health conditions analysed per study varied from 7 to 22,
with prevalence of multimorbidity from 4.5% to 83%.
The leading chronic conditions were hypertension,
arthritis, diabetes, cardiac problems and skin diseases.
The most frequently reported outcomes were increased
healthcare utilisation, lowered physical functioning and
quality of life, and psychological distress.
Conclusions: Our study, a comprehensive mapping of
multimorbidity research in South Asia, reveals the
insufficient volume of work carried out in this domain.
The published studies are inadequate to provide an
indication of the magnitude of multimorbidity in these
countries. Research into clinical and epidemiological
aspects of multimorbidity is warranted to build up
scientific evidence in this geographic region. The wide
heterogeneity observed in the present review calls for
greater methodological rigour while conducting these
epidemiological studies.
Trial registration number: CRD42013005456.
INTRODUCTION
In the past few decades, chronic diseases
have replaced infectious diseases and
assumed the dominant healthcare burden.1
Coexistence of multiple chronic diseases in a
single individual, known as multimorbidity,
is increasingly becoming the norm.2
Individuals with multimorbidity register
higher mortality rates, incur increased
healthcare expenditure, are frequently hospi-
talised, and experience disturbed physical
and mental health, affecting overall function-
ing and quality of life.3 4 Owing to its nega-
tive consequences and high resource use
associated, multimorbidity has attracted
considerable interest and attention among
clinicians and public health researchers
alike.5 A considerable corpus of primary care
research over the last decades has been
performed around this area, in developed
countries.6–9 Prevalence estimates in these
countries have shown varying ﬁgures ranging
from 39.5% in Spain to 13% in the
Netherlands.10 11 A study involving primary
care patients in Scotland has revealed one
quarter of patients to have multimorbidity,
with one-third of them being young.12 This
study strongly urged the global health com-
munity to be adequately prepared to be
responsive to the challenges of multimorbid-
ity. Nonetheless, the population-based studies
Strengths and limitations of this study
▪ Our systematic review identifies a large knowl-
edge gap in the epidemiology of multimorbidity
in South Asia, where few studies have been con-
ducted to investigate multimorbidity.
▪ Our review is the first to undertake a comprehen-
sive mapping of multimorbidity studies in South
Asia and demonstrates the need for systematic
enquiries on multimorbidity to be undertaken in
this region.
▪ Since multimorbidity is not well indexed in litera-
ture databases, we might have inadvertently
omitted some studies.
▪ A quantitative synthesis could not be performed
due to a large amount of heterogeneity among
the selected studies.
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from several middle income countries such as Ghana,
Brazil and South Africa reported prevalence of multi-
morbidity as high as 38.5%.13–15 However, to date, the
majority of research from low- and middle-income coun-
tries (LMICs) are focused on a single or speciﬁc illness,
or on the coexistence of a relatively small number of dis-
eases such as cardiovascular ailments, diabetes and
cancer, and the presence of unrelated or incongruent
multiple chronic conditions has not been investigated in
detail.16 17
Together, home to approximately one-ﬁfth of the
world’s population, South Asia deserves special attention
in the context of multimorbidity. All of the seven coun-
tries in this region are LMICs.18 Along with rapid urban-
isation and demographic transition, these countries are
now experiencing a shift from communicable to non-
communicable diseases, and multimorbidity could be an
emergent phenomenon. Given the high younger popu-
lation, the projected magnitude can be enormous, and
the extant unprepared health system and limited
resources could cumulatively add to the adverse impacts.
Several studies are available from individual South
Asian countries on the level of selected or individual
chronic diseases among the adult population. However,
to the best of our knowledge, to date, there are no com-
prehensive systematic reviews on multimorbidity among
adults residing in the South Asian region, and therefore
a contextual understanding essential for developing and
aligning health services to meet patient care is lacking.
The present systematic review is the ﬁrst attempt to land-
scape multimorbidity research in South Asia and to sys-
tematically evaluate published studies (longitudinal,
cross sectional) documenting occurrence, pattern and
consequences of multimorbidity in the adult population
in South Asian countries, thus enabling comparison with
other regions. It is expected that the information
acquired would identify existing knowledge gaps and
guide future research needs into multimorbidity in this
region. The speciﬁc objectives were to (1) estimate the
prevalence of multimorbidity, and (2) study the patterns
of occurrence and its consequences in South Asia. The
focus of the review was limited to multimorbidity
deﬁned as the co-occurrence of multiple chronic dis-
eases in the same individual or mean disease count per
individual.
METHODS
A systematic review of published studies reporting multi-
morbidity among adults residing in South Asia was
undertaken in accordance with the Preferred Reporting
Items for Systematic reviews and Meta-Analyses
Figure 1 PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) flowchart of the literature search.
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Table 1 Studies reporting prevalence of multimorbidity in South Asia
Study Settings Sample Methods
Sl
no Study (year) Country Study period Sample size
Age in
years Settings Data collection
Number of
diseases included
1 Joshi et al,
200332
India July 1999–April
2000
200 >60 Community based (urban
and rural)
Self-reported, medical
records,
Physician’s diagnosis
27, ICD10 coding
related to diseases
2 Purty et al,
200624
India October 2002–
October 2003
320 >60 Community based (rural) Self-reported,
Physician’s diagnosis,
Laboratory investigations
15
3 Khanam et al,
201125
Bangladesh July 2003–
March 2004
625 >60 Community based (rural) Physician’s diagnosis,
Laboratory investigations
9
4 Chakraborty
et al, 200427
India January–March
2005
420 >60 Community based (rural) Self-reported >12
5 Swami et al,
200230
India 1998–1999 362 >65 Community based (86%
rural)
Self-reported,
Physician’s diagnosis
>13 (System wise)
6 Chakrabarty
et al, 201026
India 2007 495 >60 Community based (rural) Self-reported,
Physician’s diagnosis
16 (ICD-10 coding
related diseases)
7 Bhojani et al,
201316
India June 2009–
March 2010
44 514 >18 Community based (urban) Self-reported Any chronic
conditions
8 Van Minh et al,
200820
India
Bangladesh
2005 India
(N=2080)
Bangladesh
(N=8096)
25–
65 years
Community based
predominantly rural
Self-reported 7
9 Banjare and
Pradhan 201428
India October 2011–
February 2012
320 >60 Community based (rural) Self-reported 20 listed
10 Pati et al,
201423
India 2007–2010 10 978 >18 Secondary data based
WHO-SAGE wave 1
(Community based; 75%
Rural)
Self-reported 9
11 Arokiasamy
et al, 201422
India, China,
Mexico, South
Africa, Russia,
Ghana
2007–10 11 230 >18 Secondary data based
WHO-SAGE wave 1
(community based; 75%
rural)
Self-reported 8
12 Vadrevu et al,
201529
India 2009 815 ≥40 Community based (rural) Self-reported and
symptoms based
6
13 Arokiasamy
et al, 201521
India 2010 1683 >45 Secondary data LASI
LASI (72% rural)
Self-reported 7
ICD10, 10th revision of the International Statistical Classification of Diseases and Related Health Problems; LASI, Longitudinal Aging Study India; WHO-SAGE, World Health Organization-
Study on global AGEing and adult health.
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(PRISMA) statement. The methodology has been published
in PROSPERO with registration ID: CRD42013005456.
(http://www.crd.york.ac.uk/PROSPERO/).
Inclusion and exclusion criteria
Selection of articles was based on following inclusion cri-
teria, they were: (1) original studies documenting preva-
lence, patient factors associated with multimorbidity and
consequences of it; or (2) studies reporting results that
allowed calculation of prevalence; (3) studies having par-
ticipants of more than 18 years of age; (4) conducted
either in a primary care/outpatient setting or general
population from the above mentioned South Asian
countries; (5) studies that had published results between
1990 and March 2015. As multimorbidity ﬁrst came to
prominence in the early 1990s, we included articles pub-
lished in the English language between 1 January 1990
and 31 March 2015.
For those studies in which multimorbidity was not
deﬁned, we made an operational deﬁnition of ‘studies
documenting two or more chronic conditions, even
though not mentioning the term multimorbidity’. These
were also included for data synthesis. Any study that
began with a preliminary selection of index disease
(studies of comorbidity) was excluded.
Search strategy for identification of articles
We systematically explored Pub Med and EMBASE elec-
tronic databases, and Google Scholar search engines, to
locate the relevant articles. We categorised the search
terms according to location, methodology and out-
comes: (1) Location: ‘India, Pakistan, Nepal, Bhutan,
Bangladesh, Sri Lanka, Maldives, South Asia’. 18 (2)
Method: ‘prevalence, epidemiology, cluster, pattern’.
(3) Outcome: ‘multimorbidity, multimorbid,
multi-morbidity, multiple conditions, co-morbid, mul-
tiple diseases, multiple chronic diseases, multiple
chronic conditions, multiple illnesses, multiple diagno-
ses, multi-pathology, chronic condition, chronic dis-
eases’. The ‘AND’ Boolean operator was used to
combine search terms across the categories and ‘OR’
was used to combine within the categories. To broaden
the scope of our research, we also applied the linguistic
variations of multimorbidity in the search strategy.
Further, we limited the search to those studies that only
involved human participants, had abstracts available and
were published between 1 January 1990 and 31 March
2015. To obtain additional publications, reference lists
of retrieved articles were hand searched using snowbal-
ling techniques. Wherever possible, forward citations of
the studies retrieved during the literature search were
traced and screened for possible inclusion.
Furthermore, search of relevant websites, namely multi-
morbidity research network of university of Sherbrook
(http://crmcspl-blog.recherche.usherbrooke.ca/) and
WHO (http://www.who.int/en/), was also performed.
A summary of the search strategy adopted for the review
is outlined (see online supplementary appendix 1).
Data management
First, all hits obtained were gathered and duplicates
removed. Potentially relevant articles were selected
through initial title and abstract screening by two
authors (MAH and SS) independently. In the next step,
the full text copies of these relevant articles were
retrieved. We retained those articles that studied the
prevalence of more than two chronic conditions without
any index disease, even if they were not using the term
‘multimorbidity’. Articles meeting all inclusion criteria
were retained for quality assessment and data extraction.
For data extraction, a special form was constructed. Two
authors (MAH and SS) independently assessed each of
these 61 retrieved articles for inclusion, extracted data
and cross checked data extraction forms. Any discrepan-
cies regarding eligibility between the two reviewers were
resolved by consensus with two other authors (SP, CS).
Assessment of study quality
Two authors (MAH and SS) independently assessed risk
of bias and study quality, using standard ‘strengthening
the reporting of observational studies in epidemiology’
(STROBE) checklist.9 19 Any disagreement arising on
quality was sorted out in consultation with two other
authors (SP and CS). For observational study designs,
risk of bias was assessed for three domains: selection
bias, information bias (differential misclassiﬁcation and
non-differential misclassiﬁcation) and confounding. Risk
of bias for each domain was assessed as either ‘Yes’ or
‘No’. Studies that had a risk of bias in each domain,
including a risk of confounding, were classiﬁed as
having more of a risk of bias. Each reviewer independ-
ently determined a global quality score for each article,
giving one point for each STROBE item the article
addressed. To be retained in our review, articles had to
have a quality score of at least 12 of a possible 23.
Data extraction
For each included study, we extracted the following
information: (1) authors and publication year; (2) title
and journal; (3) study country and location (urban or
rural); (4) study design; (5) sampling strategy (random
or non-random); (6) sample size; (7) sample character-
istics such as age and gender; (8) number of conditions
included; (9) deﬁnition of multimorbidity considered;
(10) prevalence (overall and gender- or location-
speciﬁc) of multimorbidity; (11) consequences of multi-
morbidity in terms of health-related quality of life
(HRQoL), functional status, healthcare utilisation and
healthcare expenditure (objective or subjective); and
(12) risk factors signiﬁcantly associated with
multimorbidity.
We decided not to perform meta-analysis as we judged
that the included studies were heterogeneous in differ-
ent aspects, including: populations (different ages and
settings), variable deﬁnitions (including different deﬁni-
tions of exposures and outcomes) and analytical strat-
egies (adjustment for different confounders).
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Table 2 Characteristics of selected studies concerning prevalence of multimorbidity and risk factors
Author, year of
publication Country
Use of term
multimorbidity
in the study
Definition of
multimorbidity
Results
Prevalence Risk factors Consequences
Joshi 2003 India No Not described 83%* Not described No
Purty 2006 India No Not described 24.1% Not described No
Khanam 2011 Bangladesh Yes Two or more chronic
medical conditions
53.8% Women (OR 3.32; 1.88–5.86)
High-income group
(OR 1.93; 1.14–3.27)
No
Chakraborty 2004 India No Not described 54.4% No
Swami 2002 India No Not described 69.9% Urban
Female
No
Chakrabarty 2010 India No Not described 53.7% Not described No
Bhojani 2013 India No Not described 4.5% Not described No
Van Minh 2008 India
Bangladesh
No Not described India=5.86%
Bangladesh=10.75%
Not described No
Banjare 2014 India Yes Presence of two or more
chronic diseases
56.5% Age in years
65–70: (OR 2.33; 1.22–4.45)
70–75: (OR 4.91; 2.18–11.05)
≥75: (OR 4.65; 1.87–11.52)
SES
Fully dependent: (OR 5.21;
1.99–13.60)
Partially dependent: (OR 3.02;
1.57–6.81)
Chewing tobacco: (OR 2.82;
1.51–5.24)
No
Pati 2014 India Yes Presence of two or more
chronic diseases
8.9% Age in years
30–39: (OR 4.11; 2.18–7.74)
40–49: (OR 7.87; 4.25–14.59)
50–59: (OR 16.15; 8.83–29.54)
60–69: (OR 23.56; 13.08–42.44)
>70: (OR 39.15; 20.72–73.98)
Increase healthcare
utilisation and
expenditure
Arokiasamy 2014 India Yes Simultaneous presence of
two or more chronic
diseases
20.8% Age in years
50–59: (OR 3.12; 2.88–3.37)
60–69: (OR 5.24; 4.83–5.7)
≥70: (OR 7.53;6.9–8.26)
Widow/er (OR 1.45; 1.26–1.64)
Obese (OR 1.59; 1.48–1.71)
High risk WHR
(OR 1.25; 1.17–1.32)
Inactive PA (OR
1.13; 1.07–1.19)
Poor self-rated health
(SRH)
Increased functional
limitation
Poor quality of life
Depression
Continued
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RESULTS
Yield of search strategy
The searches mentioned above yielded 11 132 articles.
After discarding duplicates, 11 021 were selected for title
screening. Careful screening of titles identiﬁed 189 arti-
cles for abstract reading, from which 61 were shortlisted
for full text review. Finally, 13 articles were included for
this systematic review. Reasons for exclusion of the
remaining articles are indicated in ﬁgure l.
Study characteristics and quality
The key characteristics of the studies are presented in
table 1. All the studies were from India and Bangladesh.
Four studies were carried out on a nationally representa-
tive sample and the rest adopted ad hoc study
designs.20–23 All were cross-sectional and quantitative in
nature. All studies were community based. Six studies
recruited participants exclusively from rural areas,24–29
two from urban area16 30 and ﬁve included urban as well
as rural participants.20–23 31 The sample size of the
included studies varied from 90 to 44 514, and included
males as well as females. Seven studies exclusively
included participants over 60 years of age.24–28 30 32
Proportion estimation was the most frequently used stat-
istical measure. On a quality assessment scale, ﬁve
studies scored between 12 and 1824 26 27 29 30; whereas
eight studies scored more than 18,16 20–23 25 28 32
and ﬁve articles scored between 12 and 18 (see online
supplementary appendix 2).
Definition and estimation of multimorbidity
‘Multimorbidity’ was deﬁned and used in six studies
(table 2).21–23 25 28 29 The remaining seven articles men-
tioned the presence of two or more chronic conditions
without using the term ‘multimorbidity’. Twelve used a
predeﬁned list of chronic conditions ranging from 7 to
16, (see online supplementary appendix 3) and one
adopted a free listing method.16 For identiﬁcation of
patients with chronic conditions, different approaches
were used, namely, self-reports in ﬁve studies,20 21 23 27 28
self-reports and physician diagnosis in four
studies,24 26 30 32 and, in other studies, a combination of
physician’s diagnosis and laboratory investigations,25 and
both self-reported and symptom based approaches were
used.22 29 International classiﬁcation for disease coding
was used in three studies and the remaining used arbi-
trary systems of coding.26 32
Five studies had stated the objective of estimating the
prevalence of multimorbidity.21–23 28 29 The rest were
intended to identify multiple chronic conditions. The
prevalence of multimorbidity varied from 4.5%16 to
83%.32 Among the population aged 60 years or over, the
prevalence ranged from 24.1%24 to 83%,32 while for the
remaining adult population it was from 4.5%16 to
20.8%.21 Prevalence of multimorbidity among studies
adopting self-reported methodology ranged from 4.3%20
to 56.8%.16 Among studies from national representative
samples, the prevalence varied from 4.3%20 to 8.9%.23
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The only study using physician diagnosis and laboratory
investigations reported multimorbidity prevalence of
53.8%.25 The prevalence varied from 24.1%24 to 83%32
among studies that used both a self-reported and clinical
examination approach. All the studies had followed a
simple count method adding up the number of chronic
diseases.
Patterns, correlates and consequences of multimorbidity
The leading chronic conditions reported were hyperten-
sion, arthritis, diabetes, cardiac problems and skin dis-
eases (see online supplementary appendix 3). Apart
from one,28 no other studies reported the pattern of dis-
eases or commonly occurring disease clusters. The most
frequently reported consequences were increase in
healthcare utilisation,23 27 30 lowering of physical func-
tioning,21 22 disability,32 quality of life,21 healthcare
expenditure23 and psychological distress.32 Only one
study21 explored the morbidity burden or severity and
HRQoL. Four studies21–23 28 identiﬁed age to be strongly
associated with multimorbidity. Two studies22 28 consid-
ered risk factors such as tobacco use, obesity, waist hip
ratio and physical activity, for prediction of multimorbid-
ity. Three studies21 22 29 looked at the impact of multi-
morbidity on self-rated health. One study23 explored the
effect of multimorbidity on healthcare utilisation and
expenditure. Positive association between multimorbidity
and depression was reported in two articles.22 32
DISCUSSION
The present systematic review intended to summarise
the scientiﬁc evidence accumulated in the past two
decades pertaining to multimorbidity in South Asia. We
identiﬁed only 13 studies, conﬁned to two countries.
Earlier reviews by Western authors also noted the
limited representation of developing countries in multi-
morbidity research.9 South Asians have already been
shown to be an inherently high-risk group for develop-
ing cardiometabolic and other chronic diseases, and
thus multimorbidity may be signiﬁcantly prevalent in
these populations.33 Nevertheless, the scarcity of publica-
tions in our review demonstrates an obvious mismatch
between the need for work versus work accomplished in
this area.
Five studies had the primary objective of estimating
multimorbidity, while for others, it was a secondary
observation, which further reduces the strength of evi-
dence on this topic. Interestingly, six studies have
assessed the prevalence of two or more chronic condi-
tions without citing the term ‘multimorbidity’, suggest-
ing low familiarity of the researchers with this entity. Five
were published in the year 2014–2015, indicating the
recent growing interest in multimorbidity in this region.
At the same time, it also suggests the continuing foot-
hold of single disease and infectious conditions among
South Asian health system researchers.
The wide variance in prevalence estimates observed in
our review stems from the diversities in study method-
ologies. For instance, sample size estimation, age group
of the study participants, and inclusion and exclusion
criteria, differed considerably between studies, which
makes comparability difﬁcult. Similar heterogeneity was
observed in a review documenting prevalence of
comorbidities in Australia, where diverse methods and
study settings were the contributing reasons.34 Another
review on multimorbidity patterns also exhibited consid-
erable methodological variability in terms of sample size,
age and recruitment of study participants, data source
and number of base line diseases.35 Four of the 13
studies used secondary data from national surveys.20–23
None of the reported studies had the intention or
objective of looking at multimorbidity, per se.
Overall quality assessment revealed major lacunae in
methodological aspects, which included ascertainment
and case deﬁnition of multimorbidity, selection of source
population, and inclusion and exclusion criteria. Even
though some of these weaknesses were noted by the
researcher in the limitations section, none of the studies
tried to address bias. The wide heterogeneity observed
due to non-uniformity in methodology and disease screen-
ing criteria makes comparability difﬁcult and explains to
some extent the large diversity observed. Owing to the
inherent biases in the original studies’ estimation, quantiﬁ-
cation of the prevalence could not be assessed.
The majority of the authors did not describe the cri-
teria for selection of chronic diseases. Where they did,
the most common were those conditions with a high
prevalence and/or clinical relevance. As the number
and type of conditions included determines multimor-
bidity estimation, the reported prevalence in these
studies may not be reﬂective of the real burden.
Moreover, there was ambiguity in disease deﬁnitions,
such as doubt over whether ischaemic heart disease and
myocardial infarction should be considered separate
entities. Thus, efforts should be ﬁrst directed at prepar-
ing a panel of chronic diseases with standardised deﬁni-
tions of each condition. This would help in minimising
the inter-study variations, reduce possible selection bias
of speciﬁc chronic diseases, and result in more reliable
and comparable estimation of multimorbidity. Further,
none of the included studies were undertaken in a
primary care setting, which constitutes an important
knowledge gap and substantiates the earlier evidence of
non-availability exploring multimorbidity in primary care
settings in LMICs.35 In view of the integral role of
primary care in the management of patients with long-
term conditions,6 and primary care being the major
healthcare provider for the population in this region,36
future studies should include these practices in explor-
ing multimorbidity.
The study populations in most articles were aged
60 years or above, which might have introduced an
element of age bias. One possible reason could be that
most researchers have assumed multiple chronic
Pati S, et al. BMJ Open 2015;5:e007235. doi:10.1136/bmjopen-2014-007235 7
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conditions to be more akin to the geriatric population.
Multimorbidity is not limited to old age alone, as it is sig-
niﬁcantly prevalent among the young population as
well.12 Equating multimorbidity with ageing could
underestimate its real magnitude. This has important
implications, especially for South Asian countries, as the
majority of this region’s population is young and pos-
sesses the risk of escalation of burden of multiple
chronic conditions in the future.
Many authors have emphasised the importance of
examining the pattern of multimorbidity in addition to
quantifying the conditions. Identiﬁcation of high fre-
quency clusters is important for developing speciﬁc
treatment guidelines and better patient management.
However, only one study in our review explored the clus-
tering of diseases.28 The recent review on pattern of
associative multimorbidity by Prados-Torres et al35
reﬂected similar ﬁndings with lack of published litera-
ture from LMICs.
The negative health consequences of multimorbidity
have placed it in the forefront of healthcare and
research, the most relevant sequelae being increased
healthcare utilisation, decreasing HRQoL, impaired
physical functioning, poor mental health and increased
healthcare expenditure.37 38 In our review, less than half
the studies considered this aspect by assessing physical
and mental functioning and healthcare utilisation. Few
have looked at the impact of multimorbidity on HRQoL
and self-reported health. In view of the informative role
of outcome measurement in the design of interventions,
future studies investigating the burden of multimorbidity
in South Asia need to embrace this dimension.
Finally, the insufﬁcient volume of published work gath-
ered through our review is inadequate to provide an
indication of the magnitude of multimorbidity in South
Asian countries. This is both surprising and concerning
since multimorbidity is a well-recognised priority in
chronic disease research worldwide and no longer con-
sidered exotic. Increased research into clinical and epi-
demiological aspects of multimorbidity is essential to
build up the scientiﬁc evidence in this geographic
region. More importantly, the wide heterogeneity
observed in the present review insinuates the need of
greater methodological rigour while conducting these
epidemiological studies.
Study limitations
The major limitation of our systematic review is the difﬁ-
culty in ensuring that all the relevant literature has been
included. Since multimorbidity is not well indexed in lit-
erature databases we might have inadvertently omitted
some studies. We tried to compensate for this by using
an extended list of text words referring to the term mul-
timorbidity as well as including any studies reporting two
or more chronic conditions excluding comorbidity.
Owing to the large heterogeneity among the studies, we
could not perform quantitative synthesis of the preva-
lence estimates. An inherent limitation of any systematic
review is the necessity to restrict a search period, which
involves the exclusion of new studies after the end date.
This might have resulted in omission of very recent
studies.
CONCLUSIONS AND FUTURE RESEARCH
Multimorbidity still remains an unexplored area of
research in South Asia. Despite the growing prevalence
of chronic diseases, the evidence base for multimorbid-
ity and its consequences is extremely limited for this
region. Since multimorbidity is a major challenge to
primary care, prevalence studies in these settings are
recommended. Further, relevant outcome measures
such as healthcare utilisation, quality of life, activity of
daily living and healthcare expenditure should be exam-
ined in unison with prevalence. Care should be taken to
adopt a uniform operational deﬁnition of multimorbid-
ity, and an iterative list of chronic conditions contextua-
lised for individual countries should be developed while
assessing multimorbidity.
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